NewsRx

Search our medical news database

Inamori Foundation

Dr. Anthony Pawson to Receive Inamori Foundation's 24th Annual Kyoto Prize for Lifetime Achievement in ``Basic Sciences''

Published in Cancer Weekly, July 15th, 2008

The Inamori Foundation (President: Dr. Kazuo Inamori) announced that Dr. Anthony James Pawson will be among the 24th annual laureates of its Kyoto Prize, an international award that honors significant contributions to the scientific, cultural and spiritual development of humanity.

This year will mark the second time in the award's 24-year history that all three recipients are North American residents -- including the first Kyoto Prize laureates from Canada.

For 2008, the Kyoto Prize in "Basic Sciences" focuses on the field of Life Sciences: Molecular Biology, Cell Biology, and Neurobiology. Dr. Pawson, 55, a citizen of both Canada and the United...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook